Zimmer Biomet Holdings (ZBH) Shares Outstanding (Diluted Average) (2009 - 2012)
Zimmer Biomet Holdings (ZBH) recorded quarterly Shares Outstanding (Diluted Average) of $177.3 million in Q2 2012, down 0.67% quarter-over-quarter from $178.5 million in Q1 2012, and down 7.99% on a YoY basis from $192.7 million in Q3 2011.
Zimmer Biomet Holdings (ZBH) Shares Outstanding (Diluted Average) (2009 - 2012) Analysis & Trends
Zimmer Biomet Holdings' Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $177.3 million for Q2 2012.
- In Q2 2012, Shares Outstanding (Diluted Average) fell 7.99% year-over-year to $177.3 million; the TTM figure through Jun 2012 stood at $177.3 million (down 7.99% YoY), while the FY2011 annual figure was $188.7 million, down 6.17% from the prior year.
- Shares Outstanding (Diluted Average) was $177.3 million for Q2 2012 at Zimmer Biomet Holdings, down from $178.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $222.1 million in Q1 2009 to a low of $177.3 million in Q2 2012.
- Historically, Shares Outstanding (Diluted Average) has averaged $200.2 million across 4 years, with a median of $200.4 million in 2010.
- The sharpest annual moves came in 2010 and 2011: Shares Outstanding (Diluted Average) declined 8.14% in 2010, then slipped 5.09% in 2011.
- A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $215.8 million in 2009, then decreased by 6.81% to $201.1 million in 2010, then declined by 6.17% to $188.7 million in 2011, then retreated by 6.04% to $177.3 million in 2012.
- The last three Shares Outstanding (Diluted Average) figures came in at $177.3 million (Q2 2012), $178.5 million (Q1 2012), and $188.7 million (Q4 2011), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | 177.30 Mn |
| Mar 31, 2012 | 178.50 Mn |
| Dec 31, 2011 | 188.70 Mn |
| Sep 30, 2011 | 188.80 Mn |
| Jun 30, 2011 | 192.70 Mn |
| Mar 31, 2011 | 193.80 Mn |
| Dec 31, 2010 | 201.10 Mn |
| Sep 30, 2010 | 199.70 Mn |
| Jun 30, 2010 | 203.60 Mn |
| Mar 31, 2010 | 204.20 Mn |
| Dec 31, 2009 | 215.80 Mn |
| Sep 30, 2009 | 217.40 Mn |
| Jun 30, 2009 | 218.80 Mn |
| Mar 31, 2009 | 222.10 Mn |